Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa Ricciardi, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results